From:  Aflatoxin B1-DNA adducts modify the effects of post-operative adjuvant transarterial chemoembolization improving hepatocellular carcinoma prognosis

The effects of po-TACE treatment on HCC prognosis stratified by ADAs

ADAPo-TACE treatmentOSRFS
DR (95% CI)aPtrendTRR (95% CI)aPtrend
LowYes vs. no0.84 (0.58–1.20)0.330.84 (0.58–1.23)0.37
HighYes vs. no0.36 (0.24–0.53)2.67 × 10–70.40 (0.28–0.59)2.00 × 10–6
Return to article view

a Adjusted by age, sex, race, HBV and HCV status, smoking and drinking status, AFP, liver cirrhosis, and tumor grade. Ptrend: P value is calculated by trend test in the models